Aspirin Therapy Proven to Reduce Mortality Rates in People with Type 2 Diabetes
According to an Israeli study, the benefits of taking 100 and 325 mg. of aspirin daily was more beneficial to patients with type 2 diabetes than in those without diabetes. The study revealed that aspirin therapy can cut death rates among people with type 2 diabetes with coronary artery disease (CAD) by one-third.
The study, which was published in The American Journal of Medicine, revealed that a dose as small as 81 mg. of aspirin per day can have "profound, life-saving effects."
"The absolute benefit of aspirin was greater in diabetic patients than in those without diabetes," says Gerald Bernstein, MD, president of the American Diabetes Association.
Participants with type 2 diabetes who took aspirin had a 10.9 percent mortality risk from cardiac diseases compared to the 15.9 percent risk for nonusers. Additionally, there was an overall mortality rate of 18.2 percent among type 2 patients who took aspirin, compared to 26.2 percent rate for people with diabetes who did not take aspirin. By comparison, nondiabetic patients who used aspirin experienced a 4.8 percent mortality risk from cardiac diseases and a 6.9 percent risk for those who did not take aspirin.
David Vorchheimer, MD, director of the cardiac unit of Mount Sinai Medical Center in New York, recommends a daily dose of 162 mg. of aspirin to prevent cardiac disease risk. For people with diabetes who have already had a heart attack, he recommends 325 mg. of aspirin per day.
Bernstein warns that aspirin therapy should be discontinued if a patient experiences bleeding, excessive bruising or heartburn. He also says that aspirin therapy should be stopped before elective surgery.Click Here To View Or Post Comments